Biontech plans to produce mRNA vaccines in Africa

In an attempt to address covid-19 and a number of other widespread diseases in Africa, Biontech plans to establish a factory there for the production of mRNA vaccines.

Biontech CEO and co-founder Ugur Sahin | Photo: Biontech / PR

Biontech plans to expand its production to Africa by establishing an mRNA vaccine factory to combat widespread diseases including covid-19.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs